BIRINAPANT
Birinapant is a small molecule pharmaceutical. It is currently being investigated in clinical studies. The pharmaceutical is active against baculoviral IAP repeat-containing protein 2. In addition, it is known to target E3 ubiquitin-protein ligase XIAP.
Download report
Favorite
Events Timeline
Commercial
Clinical
Drug
Target
Variants
Financial
Trends
Safety
Events Timeline
5D
1M
3M
6M
YTD
1Y
2Y
5Y
Max
Events
FDA approval date
EMA approval date
Patent expiration date
Study first post date
Last update post date
Start date
Primary completion date
Completion date
Results first post date
Mock data
Subscribe for the real data
Subscribe for the real data
Commercial
No data
Clinical
Clinical Trials
14 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Leukemia | D007938 | — | C95 | 1 | — | — | — | — | 1 |
| Myeloid leukemia acute | D015470 | — | C92.0 | 1 | — | — | — | — | 1 |
| Colorectal neoplasms | D015179 | — | — | 1 | — | — | — | — | 1 |
| Neoplasms | D009369 | — | C80 | 1 | — | — | — | — | 1 |
| Non-hodgkin lymphoma | D008228 | — | C85.9 | 1 | — | — | — | — | 1 |
| Sarcoma | D012509 | — | — | 1 | — | — | — | — | 1 |
| Lymphoma | D008223 | — | C85.9 | 1 | — | — | — | — | 1 |
| B-cell chronic lymphocytic leukemia | D015451 | — | C91.1 | 1 | — | — | — | — | 1 |
| Chondrosarcoma | D002813 | — | — | 1 | — | — | — | — | 1 |
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | BIRINAPANT |
| INN | birinapant |
| Description | Birinapant is a dipeptide. |
| Classification | Small molecule |
| Drug class | inhibitor of apoptosis protein (IAP) |
| Image (chem structure or protein) |  |
| Structure (InChI/SMILES or Protein Sequence) | CC[C@H](NC(=O)[C@H](C)NC)C(=O)N1C[C@@H](O)C[C@H]1Cc1c(-c2[nH]c3cc(F)ccc3c2C[C@@H]2C[C@H](O)CN2C(=O)[C@H](CC)NC(=O)[C@H](C)NC)[nH]c2cc(F)ccc12 |
Identifiers
| PDB | — |
| CAS-ID | 1260251-31-7 |
| RxCUI | — |
| ChEMBL ID | CHEMBL3039522 |
| ChEBI ID | — |
| PubChem CID | — |
| DrugBank | DB11782 |
| UNII ID | 6O4Z07B57R (ChemIDplus, GSRS) |
Target
Agency Approved
BIRC2
BIRC2
Organism
Homo sapiens
Gene name
BIRC2
Gene synonyms
API1, MIHB, RNF48
NCBI Gene ID
Protein name
baculoviral IAP repeat-containing protein 2
Protein synonyms
apoptosis inhibitor 1, C-IAP1, Cellular inhibitor of apoptosis 1, hIAP-2, hIAP2, IAP homolog B, IAP-2, Inhibitor of apoptosis protein 2, NFR2-TRAF signalling complex protein, RING finger protein 48, RING-type E3 ubiquitin transferase BIRC2, TNFR2-TRAF-signaling complex protein 2
Uniprot ID
Mouse ortholog
Birc2 (11797)
baculoviral IAP repeat-containing protein 2 (Q62210)
Alternate
XIAP
XIAP
Organism
Homo sapiens
Gene name
XIAP
Gene synonyms
API3, BIRC4, IAP3
NCBI Gene ID
Protein name
E3 ubiquitin-protein ligase XIAP
Protein synonyms
Baculoviral IAP repeat-containing protein 4, hIAP-3, hIAP3, hILP, IAP-3, IAP-like protein, IAP-like protein 1, ILP, Inhibitor of apoptosis protein 3, RING-type E3 ubiquitin transferase XIAP, X-linked IAP, X-linked inhibitor of apoptosis protein, X-linked inhibitor of apoptosis, E3 ubiquitin protein ligase
Uniprot ID
Mouse ortholog
Xiap (11798)
E3 ubiquitin-protein ligase XIAP (Q60989)
Variants
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 1,270 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use